Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy.
Adenoviridae
/ genetics
Animals
Antigens, Neoplasm
/ genetics
Antineoplastic Agents, Immunological
/ administration & dosage
CD4-Positive T-Lymphocytes
/ immunology
Cancer Vaccines
/ administration & dosage
Cell Line, Tumor
/ transplantation
Diphtheria-Tetanus-Pertussis Vaccine
/ administration & dosage
Female
Histocompatibility Antigens Class I
/ genetics
Histocompatibility Antigens Class II
/ genetics
Humans
Immunologic Memory
Immunotherapy
/ methods
Melanoma, Experimental
/ immunology
Mice
Oncolytic Viruses
/ genetics
Poliovirus Vaccine, Inactivated
/ administration & dosage
Programmed Cell Death 1 Receptor
/ antagonists & inhibitors
T-Lymphocytes, Cytotoxic
/ immunology
Vaccines, Combined
/ administration & dosage
Journal
Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R
Informations de publication
Date de publication:
15 06 2020
15 06 2020
Historique:
received:
05
07
2019
revised:
06
12
2019
accepted:
24
02
2020
pubmed:
29
2
2020
medline:
11
11
2020
entrez:
29
2
2020
Statut:
ppublish
Résumé
Because of the high coverage of international vaccination programs, most people worldwide have been vaccinated against common pathogens, leading to acquired pathogen-specific immunity with a robust memory T-cell repertoire. Although CD8
Identifiants
pubmed: 32107211
pii: 0008-5472.CAN-19-2062
doi: 10.1158/0008-5472.CAN-19-2062
doi:
Substances chimiques
Antigens, Neoplasm
0
Antineoplastic Agents, Immunological
0
Cancer Vaccines
0
DTPP vaccine
0
Diphtheria-Tetanus-Pertussis Vaccine
0
Histocompatibility Antigens Class I
0
Histocompatibility Antigens Class II
0
Pdcd1 protein, mouse
0
Poliovirus Vaccine, Inactivated
0
Programmed Cell Death 1 Receptor
0
Vaccines, Combined
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2575-2585Subventions
Organisme : European Research Council
ID : 681219
Pays : International
Informations de copyright
©2020 American Association for Cancer Research.